Neurovance Announces FDA Acceptance of IND Application For EB-1020 SR and Initiates Phase 2a Study in Adult ADHD

Business Wire
Neurovance Announces FDA Acceptance of IND Application For EB-1020 SR and Initiates Phase 2a Study in Adult ADHD
 
View Comments (0)